Keloid
78
6
6
46
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
6 terminated out of 78 trials
88.5%
+2.0% vs benchmark
12%
9 trials in Phase 3/4
20%
9 of 46 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 46 completed trials
Clinical Trials (78)
Preoperative Silicone Ointment and Wound Healing
Genetic Analysis of Keloids
Intralesional Cryosurgery Alone Versus Combined With 5-FU and Triamcinolone for Keloids
Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids
Radiotherapy for Keloids
Comparative Study Between Intralesional Corticosteroid Injection Alone and Combined Intralesional Corticosteroid Injection With Either Long-pluse Nd YAG or Erbium Yag for Treating Hypertrophic or Keloid Scars
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
Dupilumab in the Treatment of Keloids
Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]
Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.
Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars
Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid
Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar
A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence
Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.
Ethosomal Gel Bearing Losartan 5% for Keloid Treatment
Multimodal Ultrasound Imaging Assessment on Keloid